Literature DB >> 19416294

Community-associated methicillin-resistant Staphylococcus aureus: risk factors for infection, and long-term follow-up.

Y Longtin1, P Sudre, P François, J Schrenzel, C Aramburu, R Pastore, A Gervaix, G Renzi, D Pittet, S Harbarth.   

Abstract

Uncertainty persists about risk factors for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Europe and the long-term efficacy of decolonization strategies. To evaluate risk factors for CA-MRSA in Geneva, Switzerland, a hospital-based, retrospective case-control study of 26 patients with CA-MRSA infection and 60 control patients was performed. To evaluate the long-term effect of a systematic decolonization strategy (with and without concomitant systemic antibiotic therapy) for CA-MRSA patients, a prospective cohort study of 79 patients with Panton-Valentine leukocidin-producing CA-MRSA isolates was conducted. Nationality other than European Union or Swiss (adjusted OR 6.09; 95% CI 1.07-34.65) and absence of healthcare contact (adjusted OR 0.11, 95% CI 0.02-0.59) were independent predictors of CA-MRSA infection. Forty-five cases were followed (median, 22 months) to assess the long-term efficacy of the decolonization strategy; 39/45 (86.7%) had no clinical relapse and were MRSA-negative at their last follow-up, whereas six remained MRSA-positive. Five of these six cases belonged to a family cluster. Decolonization rates were similar between infected patients and asymptomatic carriers (92.6% vs. 77.8%, p = 0.20). This study shows a lack of readily modifiable risk factors for CA-MRSA infection in this population, and suggests the potential usefulness of conducting decolonization procedures in a setting with sporadic CA-MRSA infection. Further studies are needed to elucidate the role of migration as a factor contributing to the emergence of CA-MRSA in Europe.

Entities:  

Mesh:

Year:  2009        PMID: 19416294     DOI: 10.1111/j.1469-0691.2009.02715.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

Review 1.  The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany.

Authors:  Robin Köck; Alexander Mellmann; Frieder Schaumburg; Alexander W Friedrich; Frank Kipp; Karsten Becker
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines.

Authors:  Barbara Juliane Holzknecht; Hjördis Hardardottir; Gunnsteinn Haraldsson; Henrik Westh; Freyja Valsdottir; Kit Boye; Sigfus Karlsson; Karl Gustaf Kristinsson; Olafur Gudlaugsson
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

4.  Lifestyle-Associated Risk Factors for Community-Acquired Methicillin-Resistant Staphylococcus aureus Carriage in the Netherlands: An Exploratory Hospital-Based Case-Control Study.

Authors:  Miranda M L van Rijen; Marjolein F Q Kluytmans-van den Bergh; Erwin J M Verkade; Peter B G Ten Ham; Beth J Feingold; Jan A J W Kluytmans
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

Review 5.  Analysis of comorbidity of the patients affected by staphylococcal bacteremia/sepsis in the last ten years.

Authors:  Enra Lukovac; Nada Koluder-Cimic; Meliha Hadzovic-Cengic; Rusmir Baljic; Amir Hadzic; Refet Gojak
Journal:  Mater Sociomed       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.